Human medicines European public assessment report (EPAR): Evoltra, clofarabine, Date of authorisation: 29/05/2006, Revision: 34, Status: Authorised

Submitted by Anonymous (not verified) on 22 July 2024 - 15:57

Human medicines European public assessment report (EPAR): Evoltra, clofarabine, Date of authorisation: 29/05/2006, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR): Byannli (previously Paliperidone Janssen-Cilag International), paliperidone, Date of authorisation: 18/06/2020, Revision: 4, Status: Authorised

Submitted by Anonymous (not verified) on 22 July 2024 - 15:46

Human medicines European public assessment report (EPAR): Byannli (previously Paliperidone Janssen-Cilag International), paliperidone, Date of authorisation: 18/06/2020, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Trevicta (previously Paliperidone Janssen), paliperidone, Date of authorisation: 05/12/2014, Revision: 13, Status: Authorised

Submitted by Anonymous (not verified) on 22 July 2024 - 15:45

Human medicines European public assessment report (EPAR): Trevicta (previously Paliperidone Janssen), paliperidone, Date of authorisation: 05/12/2014, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Xeplion, paliperidone, Date of authorisation: 04/03/2011, Revision: 17, Status: Authorised

Submitted by Anonymous (not verified) on 22 July 2024 - 13:46

Human medicines European public assessment report (EPAR): Xeplion, paliperidone, Date of authorisation: 04/03/2011, Revision: 17, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness